Validus Holdings, Ltd. (NYSE:VR) has been given a $55.00 target price by Keefe, Bruyette & Woods in a research note issued to investors on Thursday. The brokerage presently has a “hold” rating on the insurance provider’s stock. Keefe, Bruyette & Woods’ price objective indicates a potential upside of 4.50% from the company’s current price.

Other equities research analysts have also issued reports about the company. BidaskClub lowered Validus Holdings from a “sell” rating to a “strong sell” rating in a research note on Friday. Zacks Investment Research lowered Validus Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, April 19th. ValuEngine raised Validus Holdings from a “hold” rating to a “buy” rating in a research note on Saturday, June 3rd. Finally, Deutsche Bank AG raised their price objective on Validus Holdings from $56.00 to $59.00 and gave the stock a “hold” rating in a research note on Friday, April 28th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $57.00.

Validus Holdings (VR) traded down 0.34% during mid-day trading on Thursday, hitting $52.45. The company had a trading volume of 204,717 shares. Validus Holdings has a 52-week low of $48.77 and a 52-week high of $58.76. The firm has a market cap of $4.17 billion, a P/E ratio of 14.46 and a beta of 0.64. The stock’s 50 day moving average price is $52.82 and its 200 day moving average price is $54.67.

Validus Holdings (NYSE:VR) last issued its quarterly earnings results on Thursday, July 27th. The insurance provider reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.10. The firm had revenue of $675.27 million during the quarter, compared to analyst estimates of $922.84 million. Validus Holdings had a return on equity of 7.75% and a net margin of 11.81%. During the same period last year, the company posted $0.66 EPS. On average, equities research analysts predict that Validus Holdings will post $3.74 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Validus Holdings, Ltd. (VR) Given a $55.00 Price Target at Keefe, Bruyette & Woods” was originally reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/08/18/validus-holdings-ltd-vr-given-a-55-00-price-target-at-keefe-bruyette-woods.html.

In other news, Director Matthew J. Grayson sold 30,000 shares of the firm’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $52.67, for a total transaction of $1,580,100.00. Following the completion of the sale, the director now directly owns 61,393 shares of the company’s stock, valued at approximately $3,233,569.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Patrick Boisvert sold 1,000 shares of the stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $53.40, for a total value of $53,400.00. Following the completion of the sale, the insider now owns 5,714 shares of the company’s stock, valued at approximately $305,127.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 56,000 shares of company stock valued at $2,959,300. Corporate insiders own 2.33% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the stock. IFP Advisors Inc raised its stake in Validus Holdings by 14.0% in the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock worth $112,000 after buying an additional 265 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Validus Holdings during the second quarter worth about $116,000. The Manufacturers Life Insurance Company raised its stake in Validus Holdings by 10.1% in the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock worth $124,000 after buying an additional 219 shares during the last quarter. BNP Paribas Arbitrage SA raised its stake in Validus Holdings by 93.7% in the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock worth $138,000 after buying an additional 1,282 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Validus Holdings by 10.6% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock worth $151,000 after buying an additional 278 shares during the last quarter. Institutional investors own 97.84% of the company’s stock.

About Validus Holdings

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Receive News & Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.